<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7876057</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33584497</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7876057</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fneur.2020.594213</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Table of demographic and clinical data.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Table of demographic and clinical data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Condition</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Male</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Female</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Age</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Dementia</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>MCI</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>No CI</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>MDS-UPDRS III</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>MoCA</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Motion (mm)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>GM Prob* (%)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">PD</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="center" rowspan="1" colspan="1">17</td><td valign="top" align="center" rowspan="1" colspan="1">67.2 ± 8.1</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">31.1 ± 12.1</td><td valign="top" align="center" rowspan="1" colspan="1">26.5 ± 2.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.23 ± 0.34</td><td valign="top" align="center" rowspan="1" colspan="1">69.6 ± 1.3</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NC</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">70.7 ± 8.8</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">—</td><td valign="top" align="center" rowspan="1" colspan="1">26.6 ± 2.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.17 ± 0.13</td><td valign="top" align="center" rowspan="1" colspan="1">70.1 ± 1.3</td></tr></tbody></table><table-wrap-foot><p><italic>Data are stratified by condition (Parkinson's disease participants, PD; normal control, NC). Clinical data include cognitive diagnosis, which has three levels: dementia, mild cognitive impairment (MCI), and no cognitive impairment (No CI). The last two columns display average motion and gray matter probability in the two groups. Individual values were used as nuisance regressors in our analysis. All means are given with standard deviation (mean ± standard deviation). Other values are counts of participants belonging to that group. An asterisk indicates statistically significant differences (*p = 0.05). MoCA, Montreal Cognitive Assessment; MDS-UPDRS III, Movement Disorder Society's Revision of the Unified Parkinson's Disease Rating Scale III</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Table of demographic and clinical data.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Condition</th><th valign="top" align="center">Male</th><th valign="top" align="center">Female</th><th valign="top" align="center">Age</th><th valign="top" align="center">Dementia</th><th valign="top" align="center">MCI</th><th valign="top" align="center">No CI</th><th valign="top" align="center">MDS-UPDRS III</th><th valign="top" align="center">MoCA</th><th valign="top" align="center">Motion (mm)</th><th valign="top" align="center">GM Prob* (%)</th></tr></thead><tbody><tr><td valign="top" align="left">PD</td><td valign="top" align="center">40</td><td valign="top" align="center">17</td><td valign="top" align="center">67.2 ± 8.1</td><td valign="top" align="center">6</td><td valign="top" align="center">23</td><td valign="top" align="center">28</td><td valign="top" align="center">31.1 ± 12.1</td><td valign="top" align="center">26.5 ± 2.6</td><td valign="top" align="center">0.23 ± 0.34</td><td valign="top" align="center">69.6 ± 1.3</td></tr><tr><td valign="top" align="left">NC</td><td valign="top" align="center">19</td><td valign="top" align="center">11</td><td valign="top" align="center">70.7 ± 8.8</td><td valign="top" align="center">0</td><td valign="top" align="center">9</td><td valign="top" align="center">21</td><td valign="top" align="center">—</td><td valign="top" align="center">26.6 ± 2.6</td><td valign="top" align="center">0.17 ± 0.13</td><td valign="top" align="center">70.1 ± 1.3</td></tr></tbody></table></div>Data are stratified by condition (Parkinson's disease participants, PD; normal control, NC). Clinical data include cognitive diagnosis, which has three levels: dementia, mild cognitive impairment (MCI), and no cognitive impairment (No CI). The last two columns display average motion and gray matter probability in the two groups. Individual values were used as nuisance regressors in our analysis. All means are given with standard deviation (mean ± standard deviation). Other values are counts of participants belonging to that group. An asterisk indicates statistically significant differences (*p = 0.05). MoCA, Montreal Cognitive Assessment; MDS-UPDRS III, Movement Disorder Society's Revision of the Unified Parkinson's Disease Rating Scale III.</transformed-table></extracted-table></extracted-tables-set>